Board Stats

Navidea Biopharmaceuticals, Inc.

Y! IH NAVB EXPRESS NAVB Advanced Due Diligence NAVB Oldtimers Lounge TME Macrophage Therapeutics Tx Potential-McGrath Basic Immune Cell Functions Immune Cells M1 and M2 Basics 2022- Magical Mystery Tour of Macrophges

NAVB / Message Board

BOARD

GROUPS

Written By On Topic Only -- All Messages

Hide Replies

Keyword
Subject

Between			and
Rec'd By

Authored By
Minimum Recs

MSG #	SUBJECT	TYPE	AUTHOR	SENTIMENT	RECS	DATE POSTED
40576	Combined therapies for mice tumor targeting F4/80 M2/M1 TAM result in high cure rates	GN	moneyonomics		3	12/9/2023 6:34:42 PM

40575	Pitzalis:RA-OA shared histopathological pathotypes of pauci and diffuse-lympho differ	GN	moneyonomics		1	12/8/2023 7:23:27 PM

40574	M1/M2, etc.related therapeutic strategies and construction of drug delivery systems-C	GN	moneyonomics		1	12/8/2023 7:19:44 PM

40573	Reprograming TAMs.promising for BreastCancer anti-metastatic interventions..EU-Canada	GN	moneyonomics		1	12/7/2023 5:45:46 PM

40572	Re: 2023 ASM transcript-TAMs/immuno pre. results this week-hope smiles all around Navidea	GN	moneyonomics		0	12/7/2023 2:30:46 PM

40571	Re: 2023 ASM transcript-TAMs/immuno pre. results this week-hope smiles all around Navidea	GN	alf33		2	12/7/2023 1:37:39 PM

40570	Re: Patent 11833170B2 issued to Navidea-Max.Target Tissue Therapeutics Uptake-Off T Block	GN	moneyonomics		1	12/7/2023 12:58:17 PM

40569	Re: 2023 ASM transcript-TAMs/immuno pre. results this week-hope smiles all around Navidea	GN	moneyonomics		0	12/7/2023 12:28:36 PM

40568	Re: Patent 11833170B2 issued to Navidea-Max.Target Tissue Therapeutics Uptake-Off T Block	GN	co3aii		1	12/7/2023 12:26:45 PM

40567	Re: 2023 ASM transcript-TAMs/immuno pre. results this week-hope smiles all around Navidea	GN	alf33		0	12/7/2023 11:59:32 AM

Go to Msg #

BOARDS Sign In for Filters